Adelman Associates Press Releases

• Published on September 16, 2025 - 10:30 GMT

  

  BioVentrix Appoints Mark H. Ravich as Independent Board Member

  Seasoned Executive Brings Strategic Insight and Financial Expertise to Support Company’s Governance and Funding Initiatives MANSFIELD, MA, UNITED STATES, September 16, 2025 /⁨EINPresswire.com⁩/ -- BioVentrix, Inc., a private clinical-stage medical device …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on September 10, 2025 - 10:30 GMT

  

  BioVentrix Appoints William T. Abraham, MD and Rishi Puri, MD, PhD, FRACP to Board of Directors

  Renowned cardiovascular experts bring decades of clinical, research & leadership experience to support BioVentrix’s mission of advancing heart failure treatment MANSFIELD, MA, UNITED STATES, September 10, 2025 /⁨EINPresswire.com⁩/ -- BioVentrix, Inc., …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on August 27, 2025 - 10:30 GMT

  

  BioVentrix Names Vinod H. Thourani, MD and Marat Fudim, MD, MHS as National Co-Principal Investigators for RELIVE Trial

  Renowned Cardiologists to Lead Pivotal Trial Evaluating the BioVentrix Revivent System for Heart Failure Patients MANSFIELD, MA, UNITED STATES, August 27, 2025 /⁨EINPresswire.com⁩/ -- BioVentrix, Inc., a medical device company focused on developing …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on January 21, 2025 - 13:00 GMT

  

  BioVentrix® Names Steven Chartier President and Co-Chief Executive Officer

  Brings Extensive Leadership Experience to Senior Management Team MANSFIELD, MA, UNITED STATES, January 21, 2025 /⁨EINPresswire.com⁩/ -- BioVentrix®, Inc., a specialty medical device company serving cardiothoracic surgeons and their patients with …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...